Also, recently a study of colon cancer patients showed that PIK3CA mutations did not confer any significant effect on mortality among patients with KRAS-mutated tumors and is consistent with our findings on tumors growth in HCT116 cells [32]. This evidence concerns the gene KRAS and malignant colon neoplasm.